TK
Tomoyuki Koga
Research areas: Medicine · Oncology · Glioma Diagnosis and Treatment · Vascular Malformations Diagnosis and Treatment · Vascular Malformations and Hemangiomas
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (73)
- Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma Save
- Stem cell modeling of nervous system tumors Save
- Age-Dependent Hemorrhage Risk and Obliteration Benefit After Radiosurgery for Brain Arteriovenous Malformation Save
- Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity Save
- Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma Save
- Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars Save
- Pioneering models of pediatric brain tumors Save
- TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo Save
- Structural studies of SALL family protein zinc finger cluster domains in complex with DNA reveal preferential binding to an AATA tetranucleotide motif Save
- Erratum Save
- Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies Save
- High Dose Radiosurgery Targeting the Primary Tumor Sites Contributes to Survival in Patients With Skull Base Chordoma. Save
- Structural Insights into At-Rich DNA Recognition by Sall Family Proteins Save
- Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug Save
- PTEN deficiency leads to proteasome addiction Save
- PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response Save
- PI3K-GAMMA INHIBITION SUPPRESSES ACCUMULATION OF GLIOBLASTOMA-ASSOCIATED MICROGLIA TO RECAPITULATE THE MICROENVIRONMENT OF EXCEPTIONAL RESPONDERS Save
- SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability. Save
- Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors. Save
- Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors. Save